Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
126.20
-0.06 (-0.05%)
At close: Jan 17, 2025, 4:00 PM
126.08
-0.13 (-0.10%)
After-hours: Jan 17, 2025, 5:47 PM EST
Intra-Cellular Therapies Market Cap
Intra-Cellular Therapies has a market cap or net worth of $13.41 billion as of January 21, 2025. Its market cap has increased by 100.61% in one year.
Market Cap
13.41B
Enterprise Value
12.42B
1-Year Change
100.61%
Ranking
Category
Stock Price
$126.20
Market Cap Chart
Since January 7, 2014, Intra-Cellular Therapies's market cap has increased from $332.00M to $13.41B, an increase of 3,938.54%. That is a compound annual growth rate of 39.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 13.38B | 51.10% |
| Dec 31, 2024 | 8.85B | 28.46% |
| Dec 29, 2023 | 6.89B | 37.53% |
| Dec 30, 2022 | 5.01B | 17.54% |
| Dec 31, 2021 | 4.26B | 67.27% |
| Dec 31, 2020 | 2.55B | 34.44% |
| Dec 31, 2019 | 1.90B | 204.19% |
| Dec 31, 2018 | 623.30M | -21.13% |
| Dec 29, 2017 | 790.30M | 21.04% |
| Dec 30, 2016 | 652.90M | -71.79% |
| Dec 31, 2015 | 2.31B | 345.98% |
| Dec 31, 2014 | 518.90M | 56.30% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |